Skip to content
PubMed This is a summary of 93 peer-reviewed journal articles Updated
Neurology

Frontotemporal Dementia with Motor Neuron Disease (FTD-ALS): A Patient Guide

At a Glance

FTD-ALS is a spectrum in which changes in behavior, thinking, or language occur alongside motor neuron weakness. A coordinated care team should address breathing, swallowing, safety, communication, caregiver support, and early legal planning.

Disclaimer: This guide supplements—not replaces—individual neurologic, respiratory, swallowing, genetic, legal, and palliative-care advice. The bracketed codes indicate the medical literature citations supporting these statements.

Frontotemporal dementia with motor neuron disease (FTD-ALS) is a complex neurodegenerative condition where two different types of decline—cognitive and physical—unfold at the same time. While doctors once viewed these as separate diseases, they are now understood as part of a single biological spectrum [1].

Understanding the Spectrum Terminology:
Not every person gets full dementia and full ALS. The accepted ALS-frontotemporal spectrum includes subtle cognitive or behavioral impairment, ALS with behavioral or cognitive impairment, and full ALS-FTD. Motor, cognitive, behavioral, and language features can emerge in different orders and degrees.

In this spectrum, the brain’s frontal and temporal lobes, which govern personality and language, deteriorate alongside the motor neurons that control muscle movement. This progression means that a person may experience changes in behavior, empathy, and judgment while simultaneously facing muscle weakness and speech difficulties [2].

The biological bridge between these two conditions is often found in the behavior of a protein called TDP-43, which misfolds and clumps within nerve cells in most cases, or through a specific genetic repeat expansion known as C9orf72 [3]. These underlying mechanisms cause a cascade of damage that disrupts how cells function and communicate. For caregivers, understanding this link is vital because it explains why a loved one’s “personality changes” are just as much a physical symptom of the disease as their “muscle weakness.” The behavior is not a choice; it is a direct result of the brain’s changing structure [4].

Living with ALS-FTSD requires a specialized approach to care that prioritizes several critical areas. First, receiving care from a multidisciplinary team is essential, as it brings together neurologists, therapists, and social workers who can address both the physical and behavioral symptoms in one place [5]. Second, proactive support for breathing and swallowing is the cornerstone of managing the physical side of the disease [6]. Third, because the condition can affect a person’s reasoning and safety awareness, caregivers must focus on behavioral management and home safety to prevent accidents [7]. Finally, because the window for clear communication can be short, completing advanced directives and legal planning early—while the person still has the capacity to express their wishes—is a high priority [8].

While the dual nature of this diagnosis is undeniably challenging, being informed and supported allows you to stay ahead of the disease’s progression. By focusing on symptom management, safety, and early planning, you can help preserve your loved one’s comfort and dignity throughout their journey. This guide is designed to empower you with the knowledge needed to navigate these complexities alongside your medical team [9].

Common questions in this guide

What is FTD-ALS, and is it the same as ALS or frontotemporal dementia?
FTD-ALS describes an overlap spectrum in which changes in thinking, behavior, or language occur alongside motor neuron disease. Some people have mainly motor symptoms with mild cognitive or behavioral changes, while others develop the full combination of ALS and frontotemporal dementia.
What symptoms can occur with FTD-ALS?
Symptoms may include personality or behavior changes, reduced empathy, poor judgment, apathy, and language or thinking problems. Muscle weakness, speech difficulties, and changes in breathing or swallowing can occur as motor neuron disease progresses, and symptoms may appear in different orders.
Why can someone with FTD-ALS seem to have a different personality?
The disease can damage the brain areas that help control personality, empathy, judgment, and behavior. These changes are physical symptoms of the illness rather than a deliberate choice, although the person may still need support and supervision.
What specialists should be involved in FTD-ALS care?
A coordinated team may include neurologists, movement and cognitive or behavioral specialists, therapists, respiratory and swallowing professionals, and social workers. Working together helps the team address physical symptoms, communication, behavior, safety, and caregiver needs.
How can caregivers help with breathing, swallowing, and safety?
Caregivers should ask the clinical team how to watch for new breathing or swallowing changes and what to do if they appear. Because judgment and safety awareness may change, the home may also need practical safety adjustments and a plan for managing apathy or resistance.
Why should advance directives and legal planning happen early?
FTD-ALS can affect communication, reasoning, and the ability to make decisions. Discussing values, appointing decision-makers, and documenting care preferences early can help ensure the person's wishes guide future medical and legal decisions.
How is decision-making capacity evaluated in FTD-ALS?
A clinician can assess whether the person understands information, appreciates the consequences of choices, and can communicate a consistent decision. Capacity can vary by decision and over time, so the treating team may repeat the assessment and involve the patient as much as possible.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on the current symptoms, does my loved one fit the profile of ALS with behavioral impairment (ALS-bi) or the full FTD-ALS diagnosis?
  2. 2.How will our care team coordinate between the movement specialists and the cognitive/behavioral specialists?
  3. 3.What is the best way to monitor for new respiratory or swallowing changes while also managing behavioral apathy or resistance?
  4. 4.Can you provide a formal assessment of decision-making capacity to help us understand how much the patient can participate in planning?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (9)
  1. 1

    Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria.

    Strong MJ, Abrahams S, Goldstein LH, et al.

    Amyotrophic lateral sclerosis & frontotemporal degeneration 2017; (18(3-4)):153-174 doi:10.1080/21678421.2016.1267768.

    PMID: 28054827
  2. 2

    Cognitive and Behavioral Manifestations in ALS: Beyond Motor System Involvement.

    Rusina R, Vandenberghe R, Bruffaerts R

    Diagnostics (Basel, Switzerland) 2021; (11(4)) doi:10.3390/diagnostics11040624.

    PMID: 33808458
  3. 3

    Haploinsufficiency leads to neurodegeneration in C9ORF72 ALS/FTD human induced motor neurons.

    Shi Y, Lin S, Staats KA, et al.

    Nature medicine 2018; (24(3)):313-325 doi:10.1038/nm.4490.

    PMID: 29400714
  4. 4

    Cognition and behaviour in frontotemporal dementia with and without amyotrophic lateral sclerosis.

    Saxon JA, Thompson JC, Harris JM, et al.

    Journal of neurology, neurosurgery, and psychiatry 2020; (91(12)):1304-1311 doi:10.1136/jnnp-2020-323969.

    PMID: 33055142
  5. 5

    Pan-Asian consortium for treatment and research in ALS (PACTALS) guidelines for management of amyotrophic lateral sclerosis.

    Vucic S, Shahrizaila N, Kano O, et al.

    The Lancet regional health. Western Pacific 2025; (62()):101684 doi:10.1016/j.lanwpc.2025.101684.

    PMID: 41018945
  6. 6

    Cognitive and behavioural impairment in amyotrophic lateral sclerosis.

    Pender N, Pinto-Grau M, Hardiman O

    Current opinion in neurology 2020; (33(5)):649-654 doi:10.1097/WCO.0000000000000862.

    PMID: 32833751
  7. 7

    Sleep Disturbances in Frontotemporal Dementia.

    McCarter SJ, St Louis EK, Boeve BF

    Current neurology and neuroscience reports 2016; (16(9)):85 doi:10.1007/s11910-016-0680-3.

    PMID: 27485946
  8. 8

    Amyotrophic lateral sclerosis: a clinical review.

    Masrori P, Van Damme P

    European journal of neurology 2020; (27(10)):1918-1929 doi:10.1111/ene.14393.

    PMID: 32526057
  9. 9

    Palliative care principles in ALS.

    Shoesmith C

    Handbook of clinical neurology 2023; (191()):139-155 doi:10.1016/B978-0-12-824535-4.00007-0.

    PMID: 36599506

This page is for informational purposes only and does not constitute medical advice. It cannot replace individualized neurologic, respiratory, swallowing, genetic, legal, or palliative-care guidance for someone with FTD-ALS; discuss specific decisions with the treating team.

Get notified when new evidence is published on Frontotemporal dementia with motor neuron disease.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.